AVTX
Avalo Therapeutics, Inc.
$13.74-0.22 (-1.58%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
28 of 97 tradesExecutives investing their own money
🤖AI Insight
Latest Insider Transactions
Showing 10 of 97 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | 2026-05-28 | Doyle Mittie | CMO | Exercise Conversion | 679 | $8.04 | $5,459 | N/A | N/A |
| 2026-06-01 | 2026-05-28 | Doyle Mittie | CMO | Sale | 679 | $16.00 | $10,864 | N/A | N/A |
| 2026-06-01 | 2026-05-28 | Doyle Mittie | CMO | Exercise Conversion | 679 | $8.04 | $5,459 | N/A | N/A |
| 2026-05-26 | 2026-05-21 | Riley Jennifer | CSO | Award | 34,200 | $0.00 | $0 | N/A | N/A |
| 2026-05-26 | 2026-05-21 | Sullivan Christopher Ryan | CFO | Award | 39,900 | $0.00 | $0 | N/A | N/A |
| 2026-05-26 | 2026-05-21 | Varki Paul | CLO | Award | 24,300 | $0.00 | $0 | N/A | N/A |
| 2026-05-26 | 2026-05-21 | Doyle Mittie | CMO | Award | 43,500 | $0.00 | $0 | N/A | N/A |
| 2026-05-26 | 2026-05-21 | Neil Garry Arthur | CEO | Award | 100,200 | $0.00 | $0 | N/A | N/A |
| 2026-05-11 | 2026-05-07 | Sullivan Christopher Ryan | CFO | Exercise Conversion | 18,606 | $9.88 | $183,827 | N/A | N/A |
| 2026-05-11 | 2026-05-07 | Sullivan Christopher Ryan | CFO | Sale | 18,606 | $24.12 | $448,814 | N/A | N/A |
AVTX
CFO
Exercise Conversion
$183.8K
Sullivan Christopher Ryan18,606 shares @ $9.88
Filed 2026-05-11Trade 2026-05-07
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.